Cas no 6732-01-0 (Cholesterol Hydrogen Phthalate)
Cholesterol Hydrogen Phthalate Chemical and Physical Properties
Names and Identifiers
-
- Cholest-5-en-3-ol (3b)-, 3-(hydrogen1,2-benzenedicarboxylate)
- CHOLESTEROL HYDROGEN PHTHALATE
- CHOLESTERYL HYDROGEN PHTHALATE
- Phthalic Acid Monocholesterol Ester
- EINECS 229-783-9
- 2-{[(3beta)-cholest-5-en-3-yloxy]carbonyl}benzoic acid
- Cholest-5-ene-3.beta.-yl hydrogen phthalate
- NSC 59691
- F87435
- SCHEMBL1296888
- DTXSID701306246
- 2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonyl]benzoic acid
- 6732-01-0
- AKOS015838964
- NS00047266
- Cholest-5-en-3beta-yl hydrogen phthalate
- NSC-59691
- DNRPYEJJPBQNQB-MMFRCHASSA-N
- NSC59691
- CS-0183062
- MFCD00046245
- Cholest-5-en-3-ol (3.beta.)-, hydrogen 1,2-benzenedicarboxylate
- cholesterol hydrogen-phthalate
- 2-({[(1R,3AS,3BS,7S,9AR,9BS,11AR)-9A,11A-DIMETHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-1H,2H,3H,3AH,3BH,4H,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-YL]OXY}CARBONYL)BENZOIC ACID
- Cholesterol Hydrogen Phthalate
-
- MDL： MFCD00046245
- Inchi： 1S/C35H50O4/c1-22(2)9-8-10-23(3)29-15-16-30-28-14-13-24-21-25(17-19-34(24,4)31(28)18-20-35(29,30)5)39-33(38)27-12-7-6-11-26(27)32(36)37/h6-7,11-13,22-23,25,28-31H,8-10,14-21H2,1-5H3,(H,36,37)/t23-,25+,28+,29-,30+,31+,34+,35-/m1/s1
- InChI Key： DNRPYEJJPBQNQB-MMFRCHASSA-N
- SMILES： O(C(C1C=CC=CC=1C(=O)O)=O)[C@H]1CC[C@@]2(C)C(C1)=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]21
Computed Properties
- Exact Mass: 534.37100
- Monoisotopic Mass: 534.371
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 39
- Rotatable Bond Count: 9
- Complexity: 937
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 8
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 63.6A^2
- XLogP3: 10.3
Experimental Properties
- Density: 1.11
- Melting Point: 162.0 to 166.0 deg-C
- Boiling Point: 631.8°C at 760 mmHg
- Flash Point: 191.8°C
- Refractive Index: 1.561
- PSA: 63.60000
- LogP: 8.95160
- Vapor Pressure: 0.0±1.9 mmHg at 25°C
Cholesterol Hydrogen Phthalate Security Information
- Signal Word：warning
- Hazard Statement： H303+H313+H333
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
Cholesterol Hydrogen Phthalate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | C153370-10G |
Cholesterol Hydrogen Phthalate |
6732-01-0 | >97.0%(T) | 10G |
￥1,341.00 | 2021-05-28 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | C153370-1g |
Cholesterol Hydrogen Phthalate |
6732-01-0 | 97% | 1g |
￥299.90 | 2023-09-03 | |
| TRC | C274445-2.5g |
Cholesterol Hydrogen Phthalate |
6732-01-0 | 2.5g |
$ 155.00 | 2022-04-01 | ||
| TRC | C274445-5g |
Cholesterol Hydrogen Phthalate |
6732-01-0 | 5g |
$ 275.00 | 2022-04-01 | ||
| TRC | C274445-10g |
Cholesterol Hydrogen Phthalate |
6732-01-0 | 10g |
$ 435.00 | 2022-04-01 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | C869343-1g |
Cholesterol Hydrogen Phthalate |
6732-01-0 | 97% | 1g |
296.00 | 2021-05-17 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | C0692-10g |
Cholesterol Hydrogen Phthalate |
6732-01-0 | 97.0%(T) | 10g |
￥2385.0 | 2022-06-10 | |
| abcr | AB140122-10 g |
Cholesterol hydrogen phthalate; . |
6732-01-0 | 10 g |
€390.70 | 2023-07-20 | ||
| 1PlusChem | 1P003PBJ-5g |
Cholesterol hydrogen phthalate |
6732-01-0 | ≥97% | 5g |
$238.00 | 2025-02-20 | |
| A2B Chem LLC | AB71983-5g |
CHOLESTEROL HYDROGEN PHTHALATE |
6732-01-0 | 97% | 5g |
$413.00 | 2024-04-19 |
Cholesterol Hydrogen Phthalate Suppliers
Audited Supplier
Cholesterol Hydrogen Phthalate Related Literature
-
Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
-
Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
Related Categories
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Cholestane steroids Cholesterols and derivatives
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Cholesterols and derivatives
Additional information on Cholesterol Hydrogen Phthalate
Comprehensive Overview of Cholesterol Hydrogen Phthalate (CAS No. 6732-01-0): Properties, Applications, and Industry Insights
Cholesterol Hydrogen Phthalate (CAS No. 6732-01-0) is a specialized ester derivative formed by the reaction of cholesterol and phthalic acid. This compound has garnered significant attention in pharmaceutical, cosmetic, and material science research due to its unique amphiphilic properties. The molecular structure combines the hydrophobic steroid backbone of cholesterol with the hydrophilic phthalate group, making it a versatile intermediate for drug delivery systems and biocompatible coatings.
Recent studies highlight the growing demand for Cholesterol Hydrogen Phthalate in nanotechnology applications, particularly in lipid-based nanoparticle formulations for mRNA vaccines—a topic dominating scientific discussions post-COVID-19. Researchers are exploring its role in stabilizing lipid bilayers, a critical factor for optimizing vaccine efficacy and shelf-life. This aligns with trending searches like "lipid nanoparticles for drug delivery" and "cholesterol derivatives in vaccines," reflecting public interest in cutting-edge medical advancements.
From a synthetic chemistry perspective, CAS No. 6732-01-0 serves as a key precursor for liquid crystal materials used in display technologies. Its ability to form ordered mesophases at specific temperatures makes it valuable for developing energy-efficient OLED screens—an area experiencing rapid growth due to the global shift toward sustainable electronics. Industry forums frequently discuss queries such as "cholesteric phase materials" and "phthalate esters in electronics," underscoring its relevance.
In cosmetic science, Cholesterol Hydrogen Phthalate functions as an emulsion stabilizer and viscosity modifier in premium skincare products. With consumers increasingly searching for "clean-label ingredients" and "non-irritating formulations," this compound offers advantages over traditional surfactants by reducing skin barrier disruption—a feature highlighted in dermatological studies indexed in PubMed.
Environmental considerations are also shaping research around CAS No. 6732-01-0. Unlike some conventional phthalates, its cholesterol moiety enhances biodegradability, addressing concerns about persistent organic pollutants. Laboratories are investigating its use in green chemistry protocols, responding to regulatory trends like the EU's Chemicals Strategy for Sustainability. This positions Cholesterol Hydrogen Phthalate as a candidate for safer alternatives in polymer plasticizers—a hot topic in ESG (Environmental, Social, and Governance) reports.
Analytical characterization of this compound involves advanced techniques such as HPLC-MS and NMR spectroscopy, with purity standards exceeding 98% for pharmaceutical-grade material. Quality control protocols must account for potential isomers, a technical aspect often queried in chromatography forums. The compound's melting point (158-162°C) and solubility profile (soluble in DMSO, chloroform) make it suitable for organic synthesis workflows.
Market analysts project steady growth for Cholesterol Hydrogen Phthalate derivatives, driven by expanding applications in targeted cancer therapies and diagnostic imaging agents. Patent filings reveal innovative uses in contrast media for MRI scans, leveraging its ability to chelate gadolinium ions. Such developments resonate with search trends around "theranostic agents" and "molecular imaging probes."
For researchers handling CAS No. 6732-01-0, proper storage conditions (2-8°C under nitrogen) and handling precautions (use of anhydrous solvents) are critical to maintain stability. Technical databases frequently address questions about its hydrolysis resistance compared to other cholesterol esters—an important parameter for formulation scientists.
The future trajectory of Cholesterol Hydrogen Phthalate research may focus on enzyme-responsive variants for smart drug release systems, aligning with precision medicine initiatives. As AI-driven drug discovery accelerates, computational studies of its molecular docking properties could unlock new therapeutic applications, making this 70-year-old compound unexpectedly relevant in 21st-century science.
6732-01-0 (Cholesterol Hydrogen Phthalate) Related Products
- 2641-40-9(Cholest-5-en-3-ol (3b)-, 9-anthracenecarboxylate (9CI))
- 604-32-0(Cholesterol Benzoate)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
